Table 4 Secondary outcomes
Endpoint | Overall | ADAPT | SAVE | p Value |
|---|---|---|---|---|
First-pass mTICI ≥2b | 48.5% | 33.3% | 59.6% | 0.019 |
Carotid T | 27.3% | 11.5% | 41.4% | 0.323 |
M1 segment | 57.4% | 41.7% | 67.2% | 0.361 |
M2 segment | 63.6% | 60.0% | 66.7% | 1 |
First-pass mTICI ≥2c | 27.5% | 16.7% | 35.4% | 0.171 |
Carotid T | 16.4% | 0.0% | 31.0% | 0.038 |
M1 segment | 36.2% | 30.6% | 39.7% | 1 |
M2 segment | 18.2% | 10.0% | 25.0% | 1 |
Device-passes (Median, IQR) | – | 2, 2–3 | 1, 1–2 | < 0.001 |
Carotid T | – | 3, 2–5 | 2, 1–3 | < 0.001 |
M1 segment | – | 2, 1–3 | 1, 1–2 | 0.133 |
M2 segment | – | 1, 1–2 | 1, 1–2 | 1 |
ENT | 12 (7) | 9 (12.5) | 3 (3) | 0.570 |
Carotid T | 6 (10.9) | 6 (23.1) | 0 (0) | 0.152 |
M1 segment | 5 (5.3) | 3 (8.3) | 2 (3.4) | 1 |
M2 segment | 1 (4.5) | 0 (0) | 1 (8.3) | 1 |
mRS on 90 d (Median, IQR) | 3, 2–5 | 3, 1–6 | 1 | |
Post interventional SAB | 27 (15.8) | 15 (20.8) | 12 (12,1) | 1 |
sICH | 8 (4.8) | 3 (4.2) | 5 (5.2) | 1 |